Optimizing the delivery of chemotherapy in the setting of immunotherapy in a preclinical glioblastoma model

Eitemau Tebyg

• Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
  gan: Garzon-Muvdi, Tomas, et al.
  Cyhoeddwyd: (2018)
• Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
  gan: Mathios, Dimitrios, et al.
  Cyhoeddwyd: (2016)
• IT-21 PD-1 BLOCKADE SHOWS SYNERGISTIC SURVIVAL, ANTI-TUMOR IMMUNE RESPONSE AND LONG-TERM MEMORY WITH INTERSTITIAL BUT NOT SYSTEMIC CHEMOTHERAPY: STUDY IN A MURINE GLIOBLASTOMA MODEL
  gan: Mathios, Dimitrios, et al.
  Cyhoeddwyd: (2014)
• IMPS-20 COMBINATION THERAPY WITH ANTI-PD-1, ANTI-TIM-3, AND FOCAL RADIATION RESULTS IN REGRESSION OF MURINE GLIOMAS
  gan: Kim, Jennifer E., et al.
  Cyhoeddwyd: (2015)
• Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system
  gan: Maxwell, Russell, et al.
  Cyhoeddwyd: (2018)